Acute Myeloid Leukemia Registry
NCT05979675 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2023-08-07
Summary
All acute myeloid leukemia (AML) patients diagnosed after 1 Jan 2020 will be included to this study.
Conditions
Sponsors & Collaborators
-
Turkish Hematology Association
lead OTHER
Principal Investigators
-
Ilker Kurkcu · Sentez Cro
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-21
- Primary Completion
- 2026-12-21
- Completion
- 2026-12-21
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Registry on Hypomethylating Agents in Myeloid Neoplasms
NCT01595295 ·Status: COMPLETED
-
Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 ·Status: TERMINATED
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182 ·Status: COMPLETED
-
Frequency and Risk Factors of Acute Myeloid Leukemia
NCT05787951 ·Status: UNKNOWN
-
Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments
NCT06764459 ·Status: RECRUITING
-
Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain
NCT03435341 ·Status: COMPLETED
-
Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients
NCT07250217 ·Status: RECRUITING ·Phase: NA
-
Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid Leukemia
NCT02986620 ·Status: COMPLETED
-
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
NCT03789981 ·Status: ACTIVE_NOT_RECRUITING
-
Epidemiologic Registry PETHEMA LMA 2015
NCT02607059 ·Status: UNKNOWN
-
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003931 ·Status: COMPLETED
-
Outcomes of Acute Myeloid Leukemia Patients
NCT04392310 ·Status: UNKNOWN
-
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.
NCT03311815 ·Status: COMPLETED
-
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
NCT01385150 ·Status: COMPLETED
-
Prospective Database for Acute Myeloblastic Leukemia
NCT00538278 ·Status: UNKNOWN ·Phase: NA
-
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
NCT06956755 ·Status: RECRUITING
-
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
NCT03188874 ·Status: RECRUITING
-
Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers
NCT03337516 ·Status: UNKNOWN ·Phase: NA
-
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
NCT01252485 ·Status: RECRUITING
-
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
NCT03921047 ·Status: RECRUITING
-
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
NCT05772559 ·Status: RECRUITING
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.
NCT05127798 ·Status: UNKNOWN
-
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
NCT04259372 ·Status: COMPLETED